Deferiprone‐induced agranulocytosis: 20 years of clinical observations

Use of the iron chelator deferiprone for treatment of iron overload in thalassemia patients is associated with concerns over agranulocytosis, which requires weekly absolute neutrophil counts (ANC). Here, we analyze all episodes of agranulocytosis (n = 161) and neutropenia (n = 250) during deferipron...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Hematol
Glavni autori: Tricta, Fernando, Uetrecht, Jack, Galanello, Renzo, Connelly, John, Rozova, Anna, Spino, Michael, Palmblad, Jan
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129477/
https://ncbi.nlm.nih.gov/pubmed/27415835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24479
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items